In one paragraphArticle in Nanomedicine (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors.
Preethi B BalakrishnanDepartment of Medicine, The George Washington University, 2300 I Street NW, Washington, DC 20037, USA.ORCID 0000-0001-5576-7530 Carissa S HolmbergThe Institute for Biomedical Sciences, The George Washington University, 2300 I Street NW, Ross Hall, Room 561, Washington, DC 20037, USA.ORCID 0000-0001-5577-9910 Debbie K LedezmaDepartment of Medicine, The George Washington University, 2300 I Street NW, Washington, DC 20037, USA.ORCID 0000-0001-7922-3773 Alberto BosqueThe Institute for Biomedical Sciences, The George Washington University, 2300 I Street NW, Ross Hall, Room 561, Washington, DC 20037, USA.ORCID 0000-0002-8800-2160 Rohan FernandesDepartment of Medicine, The George Washington University, 2300 I Street NW, Washington, DC 20037, USA.ORCID 0000-0001-9439-4626 Funding
SWG 2: Cure Research Scientific Working GroupP30AI117970 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI Italo Mocchetti · 2015 to 2026
$29.6MDeveloping Pathogen Recognition Receptor Agonists as Latency Reversing AgentsR01AI124722 · NIAID · UNIVERSITY OF UTAH · PI BOSQUE, ALBERTO · 2016 to 2020
$2.1MBiomaterials-Enhanced NK Cells for Improved Elimination of the HIV ReservoirR33AI136102 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI CRUZ, CONRAD RUSSELL YOUNG, FERNANDES, ROHAN · 2020 to 2022
$1.5MTraining in HIV Persistence, Co-morbidities and TherapeuticsT32AI158105 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI BOSQUE, ALBERTO, MAGGIRWAR, SANJAY B. · 2021 to 2025
$909kNIAID NIH HHS P30 AI117970NIAID NIH HHS R01 AI124722NIAID NIH HHS R33 AI136102NIAID NIH HHS T32 AI158105
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
HIV-1HIV InfectionsNanoparticlesCD4-Positive T-LymphocytesFerrocyanidesHumansVirus ActivationVirus Latencyferric ferrocyanideFerrocyanidesHIV • HIV latent reservoirslatency reversing agentspolyinosinic-polycytidylic acidPrussian blue nanoparticles
Identifiers
PMID36734362
PMCPMC10061244
What OpenQuestion holds
Textmetadata
Read underepoch 390